Searching over 5,500,000 cases.


searching
Buy This Entire Record For $7.95

Download the entire decision to receive the complete text, official citation,
docket number, dissents and concurrences, and footnotes for this case.

Learn more about what you receive with purchase of this case.

Ratshidaho v. Pharmaceuticals, LP

United States District Court, W.D. Missouri, Southern Division

March 22, 2017

ISAAC RATSHIDAHO, Plaintiff,
v.
ASTRAZENECA PHARMACEUTICALS, LP, et al., Defendants.

          ORDER AND OPINION DENYING DEFENDANT ASTRAZENECA PHARMACEUTICALS LP'S AND ASTRAZENECA LP'S MOTION TO DISMISS

          ORTRIE D. SMITH, SENIOR JUDGE.

         Pending is Defendants AstraZeneca Pharmaceuticals LP's and AstraZeneca LP's Motion to Dismiss.[1] Doc. #32. Plaintiff's Amended Complaint alleges he suffers from Chronic Kidney Disease (“CKD”) as a result of Defendants' unlawful conduct in designing, researching, developing, testing, manufacturing, packaging, labeling, marketing, promoting, distributing, and/or selling Protonix, Nexium, Nexium 24hr, Prilosec, and Prilosec OTC. Doc. #29. Collectively, these medications are proton pump inhibitors (“PPI”) used to treat gastroesophageal reflux disease and other similar gastric disorders. Id. Plaintiff asserts claims for negligence, strict products liability, breaches of express and implied warranty, fraudulent misrepresentation and omission, and violation of the Missouri Merchandising Practices Act. Id. Defendants move to dismiss under Federal Rules of Civil Procedure 12(b)(6), 8(a)(2), and 9(b), and argue Plaintiff's claim is barred by the statute of limitations. Doc. #32. For the reasons below, the Court denies the motion to dismiss.

         I. STANDARD

         The liberal pleading standard created by the Federal Rules of Civil Procedure requires "a short and plain statement of the claim showing that the pleader is entitled to relief." Erickson v. Pardus, 551 U.S. 89, 93 (2007) (per curiam) (quoting Fed.R.Civ.P. 8(a)(2)). "Specific facts are not necessary; the statement need only 'give the defendant fair notice of what the…claim is and the grounds upon which it rests.'" Id. (citing Bell Atl. Corp. v. Twombly, 550 U.S. 544, 555 (2007)). In ruling on a motion to dismiss, the Court "must accept as true all of the complaint's factual allegations and view them in the light most favorable to the Plaintiff[ ].” Stodghill v. Wellston Sch. Dist., 512 F.3d 472, 476 (8th Cir. 2008).

To survive a motion to dismiss, a complaint must contain sufficient factual matter, accepted as true, to state a claim to relief that is plausible on its face. A claim has facial plausibility when the plaintiff pleads factual content that allows the court to draw the reasonable inference that the defendant is liable for the misconduct alleged. The plausibility standard is not akin to a probability requirement, but it asks for more than a sheer possibility that a defendant has acted unlawfully. Where a complaint pleads facts that are merely consistent with a defendant's liability, it stops short of the line between possibility and plausibility of entitlement to relief.

Ashcroft v. Iqbal, 556 U.S. 662, 678 (2009).

In keeping with these principles a court considering a motion to dismiss can choose to begin by identifying pleadings that, because they are no more than conclusions, are not entitled to the assumption of truth. While legal conclusions can provide the framework of a complaint, they must be supported by factual allegations. When there are well-pleaded factual allegations, a court should assume their veracity and then determine whether they plausibly give rise to an entitlement to relief.

Id. at 679. A claim is facially plausible if it allows the reasonable inference that the defendant is liable for the conduct alleged. See Horras v. Am. Capital Strategies, Ltd., 729 F.3d 798, 801 (8th Cir. 2013); Braden v. Wal-Mart Stores, Inc., 588 F.3d 585, 594 (8th Cir. 2009).

         For a fraud claim, a heightened pleading standard applies, requiring the plaintiff to “state with particularity the circumstances constituting fraud or mistake. Malice, intent, knowledge, and other conditions of a person's mind may be alleged generally.” Fed.R.Civ.P. 9(b). This is understood to require the plaintiff plead the “who, what, when, where, and how” of the fraud. Freitas v. Wells Fargo Home Mortg., Inc., 703 F.3d 436, 439 (8th Cir. 2013). Rule 9 is satisfied with respect to a claim of fraudulent omission if the omitted information is identified and “how or when” the concealment occurred. Cf. Great Plains Trust Co. v. Union Pac. R.R. Co., 492 F.3d 986, 996 (8th Cir. 2007).

         II. DISCUSSION

         Defendants argue dismissal for failure to state a claim upon which relief can be granted is appropriate because: (1) Plaintiff fails to allege dates, quantities, exact medication consumed, and causation, (2) Plaintiff fails to detail how AstraZenca's warnings were inadequate, and (3) Plaintiff fails to meet Rule 9(b)'s heightened pleading standard for fraud. The Court rejects these arguments and declines to dismiss Plaintiff's Amended Complaint.

         (1)

         Plaintiff alleges he ingested “Nexium, Nexium 24hr, Prilosec, Prilosec OTC, and Protonix, from approximately January 2011 to 2015....” Doc. #29, ¶4. Plaintiff further alleges he was diagnosed with CKD as a result of these medications; Defendants failed to disclose the dangers of these medications to Plaintiff's physician, Plaintiff, and the general public; and Defendants misrepresented the safety of these medications to Plaintiff's physician, Plaintiff, and the general public. Plaintiff identifies the specific National Drug Code numbers for medications marketed and sold by Defendants.

         At this stage, Plaintiff need not identify the specific instances in which he consumed a medication manufactured and sold by a Defendant. Nor is Plaintiff required to differentiate between the cause and effect of one medication manufactured by AstraZenca as compared to another medication manufactured by a different Defendant. Furthermore, Plaintiff need not prove causation. Plaintiff's Amended Complaint adequately sets forth factual information ...


Buy This Entire Record For $7.95

Download the entire decision to receive the complete text, official citation,
docket number, dissents and concurrences, and footnotes for this case.

Learn more about what you receive with purchase of this case.